AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 177 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $137,000 | +39.8% | 14,800 | +13.8% | 0.00% | – |
| Q2 2020 | $98,000 | -70.0% | 13,000 | -51.7% | 0.00% | -100.0% |
| Q4 2019 | $327,000 | -43.0% | 26,900 | -43.2% | 0.00% | 0.0% |
| Q3 2019 | $574,000 | -0.7% | 47,400 | -18.0% | 0.00% | -50.0% |
| Q2 2019 | $578,000 | +41.3% | 57,800 | +82.3% | 0.00% | 0.0% |
| Q1 2019 | $409,000 | -48.2% | 31,700 | -19.7% | 0.00% | 0.0% |
| Q3 2018 | $790,000 | -52.0% | 39,500 | -56.2% | 0.00% | -71.4% |
| Q2 2017 | $1,645,000 | -29.2% | 90,100 | -11.0% | 0.01% | -41.7% |
| Q1 2017 | $2,325,000 | +18.5% | 101,269 | +24.1% | 0.01% | +33.3% |
| Q3 2016 | $1,962,000 | – | 81,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |